These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8742929)

  • 1. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.
    Midolo PD; Lambert JR; Turnidge J
    J Gastroenterol Hepatol; 1996 Mar; 11(3):290-2. PubMed ID: 8742929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population.
    López-Brea M; Martínez MJ; Domingo D; Sánchez I; Alarcón T
    FEMS Immunol Med Microbiol; 1999 Jun; 24(2):183-8. PubMed ID: 10378418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients.
    Seppälä K; Färkkilä M; Nuutinen H; Hakala K; Väänänen H; Rautelin H; Kosunen TU
    Scand J Gastroenterol; 1992 Nov; 27(11):973-6. PubMed ID: 1455197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
    Gisbert JP; Boixeda D; de Rafael L; Redondo C; Martín de Argila C; Bermejo F
    Rev Esp Enferm Dig; 1996 May; 88(5):317-22. PubMed ID: 8764537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
    Schütze K; Hentschel E; Hirschl AM
    Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
    Scheiman JM; Chey WD; Behler EM; Crause I; Elta GH
    J Clin Gastroenterol; 1996 Oct; 23(3):170-3. PubMed ID: 8899495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
    Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V
    Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
    Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori.
    Rautelin H; Tee W; Seppälä K; Kosunen TU
    J Clin Microbiol; 1994 Apr; 32(4):1079-82. PubMed ID: 8027316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.
    Forbes GM; Collins BJ; McCullough CA; Coombs GW; Robins PD
    Aust N Z J Med; 1998 Feb; 28(1):13-7. PubMed ID: 9544380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metronidazole resistance on the eradication of Helicobacter pylori.
    Noach LA; Langenberg WL; Bertola MA; Dankert J; Tytgat GN
    Scand J Infect Dis; 1994; 26(3):321-7. PubMed ID: 7939433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.